OM1, Inc.

📍 Boston, United States🗓 Founded 2015👥 104 employees💰 Last funded Oct 2019
Biotechnology Research🌐 om1.com
Website LinkedIn
OM1 is an insights-driven technology and data company specializing in Personalized Medicine, Evidence Generation, and RWE Research powered by next-Gen A.I. platforms, regulatory-grade deep longitudinal data, and globally recognized thought leadership. Our unprecedented innovation takes RWE from Bench-to-Practice, delivering unparalleled personalized impact on the outcomes of patients and the advancement of research. We do things differently. We are pushing the boundaries of healthcare, reimagining how industry, providers, payers, and patients use real-world evidence. We are globally recognized for the integration of cutting-edge AI and data technologies. As pioneers in the field, our commitment to leveraging technology propels healthcare transformation, enhancing patient outcomes and setting new industry benchmarks.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in OM1, Inc.?
OM1, Inc. has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did OM1, Inc. last raise funding?
The most recent investment in OM1, Inc. recorded on gritt.io was in October 2019.
When was OM1, Inc. founded?
OM1, Inc. was founded in 2015.
What industry is OM1, Inc. in?
OM1, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is OM1, Inc. based?
OM1, Inc. is headquartered in Boston, United States.